Innovation for a healthier world: How the research-based vaccine manufacturers are contributing to the Decade of vaccines action plan


We welcome the timely update of the Global Action Plan on AMR (GAP), which provides a unique opportunity to take stock of progress to date and redouble efforts in addressing gaps ahead of the planned 2029 UN AMR HLM. We are broadly supportive of the proposed strategic objectives and reiterate the urgent need to advance...
Read moreNoting the previous work on digital health transformation, AI, and data governance, and the first WHO global strategy, IFPMA believes new health technologies have the potential to benefit all stages of R&D. While public health surveillance and patient outcomes can be further strengthened by AI-enhanced insights and digital health, ensuring patient trust in ethical and...
Read moreOn 22 May 2026, Fight the Fakes Alliance – of which IFPMA is a member – delivered a statement on substandard and falsified medicines at the 79th session of the World Health Assembly in Geneva. Fight the Fakes Alliance strongly welcomes the recommendation of the Member State Mechanism on Substandard and Falsified Medical Products (SFMPs)...
Read more